In this subset of Hunter syndrome patients, hormone replacement with corticosteroid, thyroid hormone, and growth hormone may be critically important to prevent endocrine-associated morbidity and, potentially, mortality. The gene discussed is GH1; the disease is mucopolysaccharidosis type 2.